Previous 10 | Next 10 |
home / stock / pclof / pclof news
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients in Europe the highest quality high-THC flower product ...
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company - Represents Third Customer in the Country Canada NewsWire PharmaCielo has received a purchase order for CBD Isolate as an API, which will be used by a large pharmaceutical company in Brazil ...
PharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant Terms Canada NewsWire Steady progress against the efficiency plans initiated in mid-2021 with the transition to the current senior management team. Exp...
PharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian Market Canada NewsWire Ease Labs Pharma, a global pharmaceutical company headquartered in Brazil , has received regulato...
PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco Canada NewsWire Represents PharmaCielo's first shipment to Africa . Morocco is pioneering the commercialization of cannabinoid products on the African continent and w...
PharmaCielo Announces TSX Venture Exchange Approval of Warrant Extension Canada NewsWire TORONTO and RIONEGRO, Colombia , Nov. 22, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of ...
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) saw revenues drop sequentially, as the company tries to shave down spending and expand its footprint abroad. The Canadian parent of a Colombia producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia...
PharmaCielo Announces Q3 2022 Financial Results Canada NewsWire In the first nine months of 2022, PharmaCielo has made shipments to 23 customers in nine countries, with continued growth expected for 2023. The Company has more than doubled Revenue to $3.8 million ...
PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Uruguay Canada NewsWire This is PharmaCielo's second pharmaceutical grade product shipment to a well-established Latin American pharmaceutical company with operations in Uruguay ...
PharmaCielo Announces Shipment of Dried Cannabis Flower to the Czech Republic, Representing the Company's First Shipment of Medicinal Grade Dried Cannabis Flower into the EU Canada NewsWire Shipment made to an established pharmaceutical distributor and clinical resea...
News, Short Squeeze, Breakout and More Instantly...
PharmaCielo Ltd. Company Name:
PCLOF Stock Symbol:
OTCMKTS Market:
All amounts expressed in Canadian dollars unless otherwise noted Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried fl...
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX:PCLOF) revealed its plans to acquire cannabis operations in Thailand. What Happened On Wednesday, the Canadian ...
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...